Visión generalGráficoNoticiasTraderScreen

UC WAR. CALL 12/24 OMV/  DE000HC82HV5  /

gettex
30/05/2024  11:47:06 Diferencia+0.0080 Bid12:10:23 Ask- Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
0.0090EUR +800.00% 0.0090
Volumen de oferta: 100,000		 -
Tamaño/ Volumen/ Formato de Ask: -		 OMV AG 60.00 - 18/12/2024 Call
GlobeNewswire 13:30 Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
GlobeNewswire 13:30 Else Nutrition’s Ready-to-Drink Kids Vanilla Shake Named Among the Best in Family-Friendly Products ...
GlobeNewswire 13:30 Pulse Oil Announces EOR Operational Progress and the Retirement of Dr. Douglas Ellenor
GlobeNewswire 13:30 Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
GlobeNewswire 13:30 PodcastOne (Nasdaq: PODC) Reports Record Fiscal Year 2024 Results
GlobeNewswire 13:30 Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patie...
GlobeNewswire 13:30 Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire 13:30 Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
GlobeNewswire 13:30 Bread Financial™ to Participate in the TD Cowen Financial Services & Fintech Summit
TeleTrader 13:24 EU calls on Israel to 'stop campaign against UNRWA'
GlobeNewswire 13:15 ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 13:05 Vigil Neuroscience to Present in Upcoming June Investor Conferences
GlobeNewswire 13:02 Incident IQ Partners with Level Access to Enhance Digital Accessibility
TeleTrader 13:01 Best Buy's Q1 revenue down 6.5% to $8.8B
GlobeNewswire 13:00 Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment ...
GlobeNewswire 13:00 Omega Therapeutics To Participate In Two Upcoming Investor Conferences
GlobeNewswire 13:00 Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Withi...
GlobeNewswire 13:00 BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conf...
GlobeNewswire 13:00 Destination XL Group, Inc. Reports First Quarter Financial Results
GlobeNewswire 13:00 PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
Newsfile Corp 13:00 UFC and Aires Tech Announce Multi-Year Global Marketing Partnership
GlobeNewswire 13:00 Beamr Cloud upgrade for enterprises: customizable video service with enhanced security and privacy
GlobeNewswire 13:00 Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
GlobeNewswire 13:00 Amplify ETFs Declares May Income Distributions for its ETFs
GlobeNewswire 13:00 SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth